Specificity, Inc. Declares Non-Reliance on 2025 Financials Due to Errors and Internal Control Weakness
Summary
Specificity, Inc. announced it can no longer rely on its 2025 annual financial statements due to identified errors, requiring a restatement and delaying its Q1 2026 report.
Key Events
-
Non-Reliance on 2025 Financials
The company identified errors in its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, leading to a declaration of non-reliance on these previously issued financial statements.
-
Delayed Q1 2026 Report
In connection with the identified errors, the company delayed the completion and filing of its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026.
-
Internal Control Weakness Identified
The underlying error was attributed to an inadvertent failure by management to obtain and review certain bank and credit card statements associated with accounts opened in mid-December 2025.
-
Preliminary Financial Adjustments
Preliminary analysis indicates an approximate understatement of expenses by $83,422, understatement of revenues by $2,500, understatement of liabilities by $121,122, overstatement of additional paid-in capital by $40,000, and understatement of cash by $202.
Analysis
Specificity, Inc. has declared that its previously issued Annual Report on Form 10-K for fiscal year 2025 cannot be relied upon. This is a critical event as it indicates a significant breakdown in financial reporting and internal controls, specifically due to management's failure to review bank and credit card statements. The identified errors, while not massive in absolute terms, represent a material portion of the company's small financial footprint and necessitate a restatement of the 2025 10-K and a delay in the Q1 2026 10-Q. This raises serious questions about the reliability of the company's financial data and its governance.
At the time of this filing, SPTY was trading at $0.28 on OTC in the Trade & Services sector, with a market capitalization of approximately $4.8M. The 52-week trading range was $0.02 to $1.89. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.